Regeneron Pharmaceuticals... (REGN)
NASDAQ: REGN
· Real-Time Price · USD
580.43
14.46 (2.55%)
At close: Aug 15, 2025, 3:59 PM
579.00
-0.25%
After-hours: Aug 15, 2025, 07:57 PM EDT
Regeneron Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2B | 3.09B | 2.49B | 2.01B | 1.92B | 2.6B | 2.73B | 2.15B | 1.94B | 3.92B | 3.11B | 3.49B | 3.4B | 3.35B | 2.89B | 3.43B | 2.07B | 1.44B |
Short-Term Investments | 5.47B | 5.26B | 6.52B | 7.78B | 7.89B | 7.92B | 8.11B | 7.76B | 6.99B | 5.04B | 4.64B | 3.53B | 4.17B | 3.7B | 2.81B | 2.36B | 1.84B | 2.07B |
Long-Term Investments | 10.06B | 9.28B | 8.9B | 8.49B | 7.72B | 6.98B | 5.4B | 5.78B | 6.33B | 6.07B | 6.59B | 5.97B | 6.42B | 7.08B | 6.84B | 5.63B | 3.9B | 3.54B |
Other Long-Term Assets | 1.54B | 1.39B | 1.14B | 1.04B | 993.8M | 470.2M | 444.1M | 409.9M | 393.2M | 349.6M | 336.4M | 320.2M | 269.9M | 262M | 216.1M | 145.9M | 142.9M | 145.7M |
Receivables | 5.61B | 5.56B | 6.21B | 6.11B | 5.72B | 5.22B | 5.67B | 5.58B | 5.12B | 5.12B | 5.33B | 5.55B | 5.16B | 4.84B | 6.04B | 5.45B | 7B | 4.17B |
Inventory | 3.21B | 3.19B | 3.09B | 3.02B | 2.87B | 2.71B | 2.58B | 2.56B | 2.51B | 2.42B | 2.4B | 2.41B | 2.22B | 1.99B | 1.95B | 2.05B | 1.98B | 2.16B |
Other Current Assets | 574.3M | 468.9M | 349.2M | 412M | 681.9M | 414.9M | 386.6M | 574.7M | 366.3M | 406.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 16.86B | 17.57B | 18.66B | 19.33B | 19.08B | 18.87B | 19.48B | 18.63B | 16.92B | 16.91B | 15.88B | 15.43B | 15.53B | 14.31B | 14.01B | 13.78B | 13.34B | 10.06B |
Property-Plant & Equipment | 4.84B | 4.69B | 4.6B | 4.44B | 4.31B | 4.23B | 4.15B | 4.01B | 3.92B | 3.88B | 3.76B | 3.7B | 3.64B | 3.56B | 3.48B | 3.4B | 3.36B | 3.26B |
Goodwill & Intangibles | 1.35B | 1.17B | 1.15B | 1.12B | 1.1B | 1.06B | 1.04B | 1.02B | 953M | 928.7M | 915.5M | 804.1M | n/a | n/a | 6.7M | n/a | n/a | n/a |
Total Long-Term Assets | 21.36B | 19.97B | 19.1B | 18.11B | 17.01B | 15.5B | 13.6B | 13.53B | 13.73B | 13.15B | 13.33B | 12.25B | 11.68B | 12.04B | 11.42B | 9.9B | 8.15B | 7.72B |
Total Assets | 38.22B | 37.55B | 37.76B | 37.44B | 36.09B | 34.37B | 33.08B | 32.16B | 30.66B | 30.06B | 29.21B | 27.68B | 27.21B | 26.35B | 25.43B | 23.67B | 21.49B | 17.77B |
Account Payables | 723.9M | 705.5M | 789.5M | 497.3M | 561.7M | 671.3M | 606.6M | 536.6M | 547.3M | 599.5M | 589.2M | 535.6M | 534.2M | 470.3M | 564M | 427M | 476M | 542.9M |
Deferred Revenue | 481.9M | 619.3M | 627.7M | 627.2M | 586M | 516.7M | 458.9M | 417.3M | 381.1M | 426.3M | 477.9M | 547.2M | 566.3M | 491.3M | 442M | 507.8M | 520M | 464.9M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 3.67B | 3.57B | 3.94B | 3.66B | 3.51B | 3.58B | 3.42B | 3.6B | 3.1B | 3.1B | 3.14B | 2.88B | 3.03B | 3.01B | 3.93B | 3.71B | 3.73B | 3.22B |
Long-Term Debt | 1.99B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B |
Other Long-Term Liabilities | 1.7B | 1.67B | 1.57B | 1.54B | 1.46B | 908.5M | 854.1M | 832.4M | 716.8M | 677.3M | 638M | 598.6M | 724.7M | 692.5M | 680.2M | 662.6M | 596.3M | 571.5M |
Total Long-Term Liabilities | 4.61B | 4.59B | 4.46B | 4.46B | 4.37B | 3.8B | 3.68B | 3.66B | 3.54B | 3.46B | 3.41B | 3.36B | 3.48B | 3.43B | 2.73B | 2.7B | 2.63B | 2.58B |
Total Liabilities | 8.28B | 8.16B | 8.41B | 8.12B | 7.88B | 7.38B | 7.11B | 7.26B | 6.64B | 6.56B | 6.55B | 6.24B | 6.52B | 6.43B | 6.67B | 6.41B | 6.36B | 5.8B |
Total Debt | 2.71B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B |
Common Stock | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K |
Retained Earnings | 33.68B | 32.38B | 31.67B | 30.76B | 29.41B | 27.98B | 27.26B | 26.1B | 25.09B | 24.12B | 23.31B | 22.11B | 20.79B | 19.94B | 18.97B | 16.74B | 15.11B | 12.01B |
Comprehensive Income | 52.5M | 29.1M | -7.9M | 60.2M | -69.9M | -77.2M | -80.9M | -176.8M | -197.7M | -181.6M | -238.8M | -275.1M | -223.8M | -170.1M | -26.2M | 9.5M | 15.7M | 16.2M |
Shareholders Equity | 29.94B | 29.39B | 29.35B | 29.33B | 28.21B | 26.99B | 25.97B | 24.9B | 24.02B | 23.5B | 22.66B | 21.44B | 20.69B | 19.91B | 18.77B | 17.26B | 15.13B | 11.98B |
Total Investments | 15.53B | 14.54B | 15.42B | 16.28B | 15.61B | 14.9B | 13.51B | 13.54B | 13.32B | 11.11B | 11.23B | 9.5B | 10.59B | 10.79B | 9.65B | 7.99B | 5.74B | 5.61B |